Body weight trajectory of non-obese asthmatics: Relationship with inhaled corticosteroids maintenance therapy
Allergy and Asthma Proceedings · 2025
DOI: 10.2500/aap.2025.46.250041 ↗Kurz gefasst
Fachartikel in der Zeitschrift Allergy and Asthma Proceedings, 2025. Verfasst von Monique Olivia Burch und 7 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Internal Medicine, Jundiaí School of Medicine, Jundiaí, Brazil. Hauptthemen laut MEDLINE: Asthma, Adrenal Cortex Hormones, Anti-Asthmatic Agents, Body Weight. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Background
It is unclear whether the continuous use of a high dose of inhaled corticosteroids (ICS) could contribute to an unfavorable trajectory in body weight.
Objectives
The objective was to evaluate whether a high dose of ICS used continuously for maintenance therapy increases the risk of an unfavorable body weight trajectory in individuals with asthma and who are not obese.
Methods
We screened consecutive individuals with chronic respiratory symptoms suggestive of asthma who underwent a medical consultation in any of the 42 public health facilities in the municipality of Jundiaí, Brazil. We included individuals with proven asthma who were ≥ 20 years of age and who had a body mass index (BMI) < 30 kg/m 2 on the day of screening for the study. Individuals participated in two study visits 12 months apart, named V 1 and V 2 . Between study visits, individuals had one intermediate consultation with their referring physician.
Results
Ninety-nine individuals used a high dose of ICS during the study and 294 used a low-medium dose. The individual with asthma and no obesity and who used a high dose of ICS had a similar risk of having obesity at V 2 compared with those who used a low-medium dose (adjusted odds ratio 1.18 [95% confidence interval, 0.46‐3.04]). The probability of gaining weight was similar between the two groups.
Conclusion
The use of a high dose of ICS for 1 year does not increase the risk of obesity among individuals with asthma and who are not obese, nor is it associated with an unfavorable body weight trajectory compared with individuals with asthma who were using a low-medium dose of ICS. This information may help reduce fears about using ICS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Department of Internal Medicine, Jundiaí School of Medicine, Jundiaí, Brazil.
- Department of Internal Medicine, Unianchieta, Jundiaí, Brazil.
- Department of Speech Therapy, Unianchieta, Jundiaí, Brazil.
- Department of Physical Therapy, Unianchieta, Jundiaí, Brazil; and.
- Department of Pathology, Jundiaí School of Medicine, Jundiaí, Brazil.
Zitieren
APA
Burch, M. O., Rocha, D. G., Belleze, L., Da Silva, M. J. O., Assuncao, R. P., Antunes, D., Mamoni, R. L., & Ponte, E. V. (2025). Body weight trajectory of non-obese asthmatics: Relationship with inhaled corticosteroids maintenance therapy. Allergy and Asthma Proceedings. https://doi.org/10.2500/aap.2025.46.250041
Vancouver
Burch MO, Rocha DG, Belleze L, Da Silva MJO, Assuncao RP, Antunes D, et al. Body weight trajectory of non-obese asthmatics: Relationship with inhaled corticosteroids maintenance therapy. Allergy and Asthma Proceedings. 2025. doi:10.2500/aap.2025.46.250041
BibTeX
@article{Burch2025,
author = {Burch, Monique Olivia and Rocha, Daniel Gimenez and Belleze, Leticia and Da Silva, Marcos Jose Oliveira and Assuncao, Renata Pletsch and Antunes, Daniel and Mamoni, Ronei Luciano and Ponte, Eduardo Vieira},
title = {Body weight trajectory of non-obese asthmatics: Relationship with inhaled corticosteroids maintenance therapy},
journal = {Allergy and Asthma Proceedings},
year = {2025},
doi = {10.2500/aap.2025.46.250041}
}
EUVIMED